-+ 0.00%
-+ 0.00%
-+ 0.00%

Update: Leo Pharma Pushes Back IPO Plans Past 2026, CEO Says

MT Newswires·11/16/2026 06:11:59
Listen to the news
06:11 AM EST, 11/16/2026 (MT Newswires) -- (Updates with additional information) Leo Pharma shelved plans for an initial public offering in 2026, Bloomberg News reported Monday, citing Chief Executive Officer Christophe Bourdon. Bourdon said that the Danish pharmaceutical company is prepared for an IPO, but its shareholders determined that the current market conditions "do not support a listing.